What is the recommended cefuroxime dose for surgical prophylaxis in adults (1.5 g IV), in children (30 mg/kg IV up to 1.5 g), and how should it be adjusted for patients with severe renal impairment (creatinine clearance <30 mL/min)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefuroxime Dosing for Surgical Prophylaxis

For surgical prophylaxis, administer 1.5 g of cefuroxime IV in adults, 30 mg/kg IV (up to 1.5 g maximum) in children, and reduce the dose to 750 mg every 12 hours in patients with severe renal impairment (creatinine clearance <30 mL/min). 1

Adult Dosing

  • Standard prophylactic dose: 1.5 g IV administered just before surgery (approximately 30-60 minutes before initial incision) 1
  • Timing is critical: Administration within 10-25 minutes before incision is associated with significantly lower surgical site infection rates compared to 61-120 minutes before incision 2
  • Prolonged procedures: Give 750 mg IV or IM every 8 hours when the procedure extends beyond the initial coverage period 1
  • Open heart surgery: Administer 1.5 g IV at induction of anesthesia, then every 12 hours for a total of 6 grams 1

Weight-Based Considerations

  • Patients weighing 80-90 kg: Double-dose (3.0 g) cefuroxime is associated with lower surgical site infection rates 3
  • Patients weighing ≥90 kg: Evidence for double-dosing benefit is inconsistent; standard 1.5 g dosing may be adequate 3
  • Contaminated wounds: Double-dose (3.0 g) prophylaxis shows significant benefit regardless of weight 3

Pediatric Dosing (>3 months of age)

  • Standard dose: 30 mg/kg IV (maximum 1.5 g) administered before surgery 1
  • Do not exceed adult maximum dose of 1.5 g per administration 1

Renal Impairment Adjustments

Creatinine clearance >20 mL/min:

  • Standard dose of 750 mg to 1.5 g every 8 hours 1

Creatinine clearance 10-20 mL/min:

  • 750 mg every 12 hours 1

Creatinine clearance <10 mL/min:

  • 750 mg every 24 hours 1
  • Hemodialysis patients: Administer an additional dose after dialysis 1

Calculating Creatinine Clearance

When only serum creatinine is available 1:

Males: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]

Females: 0.85 × male value

Administration Guidelines

  • IV infusion: Slowly inject over 3-5 minutes for direct administration 1
  • Continuous infusion: May be added to compatible IV solutions (0.9% NaCl, 5% dextrose, lactated Ringer's) 1
  • IM injection: Deep injection into large muscle mass (gluteus or lateral thigh); aspirate before injecting to avoid vascular injection 1

Common Pitfalls

  • Avoid early administration: Giving cefuroxime 61-120 minutes before incision is associated with higher infection rates compared to 0-30 minutes before incision 2
  • Single-dose limitation: While a single 1.5 g dose is effective for short procedures (≤2 hours), longer surgeries require redosing every 8 hours to maintain therapeutic levels 4, 5
  • Cardiopulmonary bypass: Standard dosing may not maintain adequate concentrations during CPB; consider an additional 1.5 g dose at CPB initiation 6, 7, 8
  • High creatinine clearance (≥125 mL/min): Standard dosing may fail to achieve pharmacodynamic targets; consider shorter dosing intervals or higher doses 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.